Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Kugelberg-Welander Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Not applicableStudy completedNCT02895789
What this trial is testing

Oxidative Capacity and Exercise Tolerance in Ambulatory SMA

Who this might be right for
Spinal Muscular Atrophy Type 3Mitochondrial Myopathy
Columbia University 42
Testing effectiveness (Phase 2)Ended earlyNCT00439569
What this trial is testing

Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III

Who this might be right for
Spinal Muscular Atrophy Type IISpinal Muscular Atrophy Type III
Westat 9
Large-scale testing (Phase 3)Active Not RecruitingNCT05626855
What this trial is testing

Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab

Who this might be right for
Spinal Muscular AtrophySpinal Muscular Atrophy Type 3Spinal Muscular Atrophy Type 2+7 more
Scholar Rock, Inc. 238
Not applicableUnknownNCT05544994
What this trial is testing

The Effect of Aerobic Exercise Training in Patients With Type III Spinal Muscular Atrophy

Who this might be right for
Neuromuscular DiseasesSpinal Muscular Atrophy Type 3
Istanbul Medipol University Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02941328
What this trial is testing

SPACE Trial: Pyridostigmine vs Placebo in SMA Types 2, 3 and 4

Who this might be right for
Spinal Muscular AtrophySMAKugelberg-Welander Disease
UMC Utrecht 39
Not applicableStudy completedNCT02003937
What this trial is testing

Aerobic Training in Patients With Spinal Muscular Atrophy Type III

Who this might be right for
Spinal Muscular Atrophy
Rigshospitalet, Denmark 15
Testing effectiveness (Phase 2)Study completedNCT03781479
What this trial is testing

Controlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 Patients

Who this might be right for
Muscular Atrophy, Spinal
Catalyst Pharmaceuticals, Inc. 13
Testing effectiveness (Phase 2)Study completedNCT02227823
What this trial is testing

Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3

Who this might be right for
Spinal Muscular Atrophy Type 3
Centre Hospitalier Régional de la Citadelle 4
Not applicableUnknownNCT02831296
What this trial is testing

Prospective Evaluation of Infants With Spinal Muscular Atrophy:

Who this might be right for
Spinal Muscular Atrophy
Massachusetts General Hospital 1,000
Not applicableActive Not RecruitingNCT03709784
What this trial is testing

Spinraza in Adult Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular AtrophySpinal Muscular Atrophy Type IISpinal Muscular Atrophy Type 3
Washington University School of Medicine 148
Not applicableStudy completedNCT05430113
What this trial is testing

Spinal Cord Stimulation in Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy Type 3Spinal Muscular Atrophy Type 4
Marco Capogrosso 3
Testing effectiveness (Phase 2)Study completedNCT01302600
What this trial is testing

Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.

Who this might be right for
Spinal Muscular Atrophy Type IISpinal Muscular Atrophy Type III Non Ambulant
Hoffmann-La Roche 165